Of these, 108 DEGs were identified in the Th-MYCN/Casp2−/− versus Th-MYCN tumor comparison and 197 DEGs in the EμMyc/Casp2−/− versus EμMyc tumors (fold change [FC] > 2 and < −2; FDR < 0.05). This evidence concerns the gene MYCN and neoplasm.